Loading…
Indaptus Therapeutics, Inc. is projected to rise to $1.72 by 2027, a +33% move from its current price of $1.29. INDP is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $1.18 | $1.29 | $1.42 | +0.02% |
| Aug 5 | $1.13 | $1.29 | $1.47 | +0.04% |
| Aug 6 | $1.10 | $1.29 | $1.52 | +0.06% |
| Aug 7 | $1.07 | $1.29 | $1.56 | +0.08% |
| Aug 8 | $1.05 | $1.29 | $1.59 | +0.10% |
| Aug 9 | $1.03 | $1.29 | $1.62 | +0.12% |
| Aug 10 | $1.01 | $1.29 | $1.65 | +0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.01 | $1.29 | $1.65 | +0.14% |
| Week 2 | $0.9123 | $1.29 | $1.83 | +0.28% |
| Week 3 | $0.8446 | $1.30 | $1.99 | +0.42% |
| Week 4 | $0.7917 | $1.30 | $2.13 | +0.56% |
| Week 5 | $0.7479 | $1.30 | $2.26 | +0.70% |
| Week 6 | $0.7105 | $1.30 | $2.38 | +0.83% |
| Week 7 | $0.6778 | $1.30 | $2.50 | +0.97% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Indaptus Therapeutics, Inc. is a clinical biotechnology company that engages in the development of anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors.
The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
It is categorized in the Healthcare sector, reflecting its focus on clinical biotechnology therapeutics and immunotherapy development.
Indaptus Therapeutics, Inc. (INDP) is currently priced at $1.29 and has a market cap of $171.88M, ranking it at 3854 in market capitalization.
The stock trades within the Healthcare space and shows a 30-day price range from $0.6973 to $2.39, with the 50-day simple moving average at $2.61 and the 200-day simple moving average at $2.44. The overall technical sentiment is NEUTRAL, and the stock exhibits an annualized volatility of 200%.
Forecasts for the stock span from 2026 through 2050, with the average price rising in several years and the maximum price showing meaningful upside in later years. Notably, the 2030 average is $1.58 with a 22.1% ROI, the 2040 average is $2.46 with a 90.8% ROI, and the 2050 average is $4.11 with a 218.8% ROI, reflecting a generally bullish longer-term trajectory.
A major floor 17.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 202.3% above — a clean break opens room to run.
A major ceiling 269.8% above — clearing it would confirm fresh momentum.
Key INDP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INDP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.66 | Sell | $1.67 | Sell |
| MA 10 | $2.13 | Sell | $1.98 | Sell |
| MA 20 | $2.38 | Sell | $2.29 | Sell |
| MA 50 | $2.61 | Sell | $2.50 | Sell |
| MA 100 | $2.38 | Sell | $2.56 | Sell |
| MA 200 | $2.44 | Sell | $4.08 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 29.66 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -203.15 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.14 | Sell |
| ROC (12) | -54.26 | Sell |
| Bollinger %B (20,2) | -0.11 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.95 | Sell |
| Awesome (5,34) | -1.18 | Sell |
| Ultimate (7,14,28) | 16.77 | Buy |
| Momentum (10) | -1.24 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 1.27 | Buy |
| ADX (14) | 17.27 | Neutral |
| ATR (14) | 0.21 | Info |
The 14-day RSI is 30, indicating a neutral momentum profile at present.
The price action features SMA50 at $2.61 and SMA200 at $2.44, with the stock currently perched near the $1.29 support level and well below the $3.90 resistance.
The 30-day range runs from a low of $0.6973 to a high of $2.39, suggesting the stock has recently traded within a relatively tight band near the support area.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.06 | $1.29 | $1.90 | 0% | Neutral | |
| $1.25 | $1.72 | $2.55 | +33% | Bullish | |
| $1.23 | $1.80 | $2.85 | +39% | Bullish | |
| $0.9629 | $1.48 | $2.46 | +15% | Neutral | |
| $0.975 | $1.57 | $2.72 | +22% | Bullish | |
| $0.8895 | $1.50 | $2.69 | +16% | Neutral | |
| $0.7395 | $1.30 | $2.41 | +1% | Neutral | |
| $1.01 | $1.85 | $3.51 | +43% | Bullish | |
| $1.17 | $2.22 | $4.33 | +72% | Bullish | |
| $1.11 | $2.20 | $4.38 | +70% | Bullish | |
| $1.11 | $2.46 | $5.40 | +91% | Bullish | |
| $1.85 | $4.12 | $9.47 | +219% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.06 | $1.29 | $1.54 | +0.00% |
| September 2026 | $0.9882 | $1.20 | $1.53 | -6.83% |
| October 2026 | $1.07 | $1.31 | $1.70 | +9.29% |
| November 2026 | $1.15 | $1.43 | $1.88 | +8.72% |
| December 2026 | $1.13 | $1.42 | $1.90 | -0.41% |
Click any year to see its month-by-month INDP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, INDP could reach as high as $1.90, with a base case around $1.29 and support toward $1.06 — roughly 0% from $1.29. Price action looks broadly range-bound.
Expect INDP to range from $1.25 to $2.55 through 2027. The $1.72 average target implies a +33% move from current prices. That is up +33% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The INDP price prediction for 2028 points to an average of $1.80 (low $1.23, high $2.85) — a potential gain of +39% on today's $1.29. Momentum favours further upside here.
In 2029, INDP is projected to trade between $0.9629 and $2.46, averaging $1.48 — a potential gain of +15% from today's $1.29. That is -18% versus the projected 2028 average. A consolidation phase looks the most probable path here.
Indaptus Therapeutics, Inc.'s 2030 outlook centres on $1.57, within a $0.975 to $2.72 range. That is up +6% on the projected 2029 average. That marks a +22% change versus current levels. Momentum favours further upside here.
By 2031, INDP could reach as high as $2.69, with a base case around $1.50 and support toward $0.8895 — roughly +16% from $1.29. A consolidation phase looks the most probable path here.
Expect INDP to range from $0.7395 to $2.41 through 2032. The $1.30 average target implies a +1% move from current prices. That is -13% versus the projected 2031 average. Price action looks broadly range-bound.
The INDP price prediction for 2033 points to an average of $1.85 (low $1.01, high $3.51) — a potential gain of +43% on today's $1.29. Buyers look set to stay in control over this stretch.
In 2034, INDP is projected to trade between $1.17 and $4.33, averaging $2.22 — a potential gain of +72% from today's $1.29. That is up +20% on the projected 2033 average. Momentum favours further upside here.
Indaptus Therapeutics, Inc.'s 2035 outlook centres on $2.20, within a $1.11 to $4.38 range. That is -1% versus the projected 2034 average. That marks a +70% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, INDP could reach as high as $5.40, with a base case around $2.46 and support toward $1.11 — roughly +91% from $1.29. Momentum favours further upside here.
Expect INDP to range from $1.85 to $9.47 through 2050. The $4.12 average target implies a +219% move from current prices. That is up +67% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in INDP today (≈ 775.193798 INDP) could be worth
$3,190.1
+$2,190.1 (+219%) by 2050 · US Dollar
Based on the average projected INDP price of $4.12 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INDPwould be worth at today's price.
$1,000 invested in INDP on Jul 31, 2025 (≈ 122.549022 INDP) would be worth
$158.09
-$841.91 (-84.2%) today · 0.16× · US Dollar
Based on a INDP entry price of $8.16 vs. today's $1.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.61 | $494.25 | -50.6% |
| 1 month ago | $2.94 | $438.78 | -56.1% |
| 3 months ago | $2.14 | $602.8 | -39.7% |
| 6 months ago | $2.01 | $641.79 | -35.8% |
| 1 year ago | $8.16 | $158.09 | -84.2% |
| All time (5.0y) ago | $248.36 | $5.19 | -99.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INDP forecast.
Our base-case forecast reaches $2.60 around 2050.
Implied market cap at $2.60: $346.43M
The multi-year outlook shows a path of gradual appreciation with notable upside in later years. In 2030, the average price is projected at $1.58 with a 22.1% ROI and a bullish sentiment, while 2040 shows an average of $2.46 and a 90.8% ROI with bullish sentiment continuing. By 2050, the average is projected at $4.11 with a 218.8% ROI and bullish sentiment, indicating substantial longer-term upside.
Some years are neutral or more modest in projection (e.g., 2026 average $1.29 with 0% ROI and 2029 average $1.48), underscoring that outcomes are not guaranteed and depend on future developments. The forecasts reflect bullish phases in numerous future years (notably 2027, 2028, 2030, 2033–2035, 2040, and 2050) alongside periods of steadier or softer growth.
Tap a question to reveal the answer.
In 2030 the forecasted average price is $1.58, with a minimum of $0.9766 and a maximum of $2.73, and a ROI of 22.1%. The sentiment for 2030 is BULLISH.
The forecast shows bullish sentiment in multiple years (e.g., 2027, 2028, 2030, 2033–2035, 2040, 2050) with positive ROI figures in several years (e.g., 33.6% in 2027, 39.4% in 2028, 22.1% in 2030, 90.8% in 2040, 218.8% in 2050). However, other years show neutral or lower projections, so outcomes are not guaranteed.
Yes. The 2050 forecast lists a max of $9.46, with an average of $4.11 and a ROI of 218.8%, and it is tagged as BULLISH.
The current price is $1.29 and the market cap is $171.88M.
RSI14 is 30, indicating neutral momentum. The SMA50 is $2.61 and the SMA200 is $2.44. Support is at $1.29 and resistance at $3.90, with a 30-day price range from $0.6973 to $2.39.
Indaptus Therapeutics, Inc. Community Discussion
0Share your Indaptus Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.